0001493152-21-004712.txt : 20210224
0001493152-21-004712.hdr.sgml : 20210224
20210224160120
ACCESSION NUMBER: 0001493152-21-004712
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210224
DATE AS OF CHANGE: 20210224
EFFECTIVENESS DATE: 20210224
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enveric Biosciences, Inc.
CENTRAL INDEX KEY: 0000890821
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 954484725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-390408
FILM NUMBER: 21672949
BUSINESS ADDRESS:
STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
BUSINESS PHONE: 239-302-1707
MAIL ADDRESS:
STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200
CITY: NAPLES
STATE: FL
ZIP: 34103
FORMER COMPANY:
FORMER CONFORMED NAME: AMERI Holdings, Inc.
DATE OF NAME CHANGE: 20150527
FORMER COMPANY:
FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC
DATE OF NAME CHANGE: 19950323
D
1
primary_doc.xml
X0708
D
LIVE
0000890821
Enveric Biosciences, Inc.
4851 TAMIAMI TRAIL N
SUITE 200
NAPLES
FL
FLORIDA
34103
239-302-1707
DELAWARE
Spatializer Audio Laboratories Inc.
AMERI Holdings, Inc.
SPATIALIZER AUDIO LABORATORIES INC
Corporation
true
John
Van Buiten
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Chief Financial Officer
David
Johnson
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Director
Chief Executive Officer and Chairman
Avani
Kanubaddi
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Executive Officer
Director
Chief Operations Officer
George
Kegler
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Sol
Mayer
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Marcus
Schabacker
4851 Tamiami Trail N
Suite 200
Naples
FL
FLORIDA
34103
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-02-09
true
true
true
false
0
8398625
0
8398625
Represents warrants to purchase up to 1,714,005 shares of common stock at an exercise price of $4.90 per share.
false
6
0
0
0
false
Enveric Biosciences, Inc.
/s/ John Van Buiten
John Van Buiten
Chief Financial Officer
2021-02-24